Shanghai Pharmaceuticals Holding Co. Ltd. has disclosed aza-ergoline derivatives acting as dopamine D2 receptor and/or D3 receptor agonists reported to be useful for the treatment of attention deficit ...

Bromocriptine is a sympatholytic D2-dopamine agonist that has been ... bromocriptine (Cycloset), a sympatholytic dopamine D 2 receptor agonist, has been approved by the U.S. Food and Drug ...

This is the first-ever drug approved for schizophrenia that does not target the D2 dopamine receptor in brain cells ... is thought to be due to the agonist activity of xanomeline or muscarinic ...